Teva Pharmaceutical Industries Limited
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $2.00B | $609.0M | $1.91B |
| Depreciation & Amortization | $908.0M | $490.0M | $499.0M |
| Depreciation | $426.0M | $308.0M | — |
| Amortization | $485.0M | $180.0M | — |
| Stock-Based Compensation | $54.0M | $63.0M | $67.0M |
| Net Cash from Operating Activities | $3.37B | $3.23B | $1.81B |
| Investing Activities | |||
| Capital Expenditures | $719.0M | $681.0M | $542.0M |
| Business Acquisitions | $0 | $4.75B | — |
| Net Cash from Investing Activities | $-916.0M | $-4.14B | $-1.35B |
| Financing Activities | |||
| Dividends Paid | $528.0M | $388.0M | $299.0M |
| Stock Repurchases | $0 | $0 | $152.0M |
| Net Cash from Financing Activities | $-2.27B | $1.36B | $-362.0M |
| Net Change in Cash | $141.0M | $366.0M | $156.0M |
| Free Cash Flow | $2.65B | $2.55B | $1.27B |